Physician profile
Robert Diraimo
NPI 1639119100
$797.08
in general payments reported to CMS, 2019-2025
11 companies · $140 in 2025
The $140 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $22.68 · 2022: $111 · 2023: $95.01 · 2024: $316 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $550.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $176.10 | 2022-2025 | Collagenase Santyl |
| Penumbra, INC. | $168.38 | 2024 | Penumbra System |
| Organogenesis INC. | $95.01 | 2023 | Puraply |
| Janssen Pharmaceuticals, INC | $92.26 | 2019-2020 | |
| Ethicon US, LLC | $88.29 | 2019-2025 | Vistaseal, Prolene, Surgicel Nu-Knit |
| Advanced Oxygen Therapy INC. | $52.32 | 2024 | Topical Oxygen Chamber For Extremities |
| Integra Lifesciences Corporation | $30.74 | 2019 | |
| Aroa Biosurgery Incorporated | $28.18 | 2024 | |
| Acera Surgical, INC. | $25.57 | 2024 | Restrata Wound Matrix |
| Boston Scientific Corporation | $23.25 | 2022 | |
| W. L. Gore & Associates, INC. | $16.98 | 2024 | Gore Excluder Iliac Branch Endoprosthesis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Diraimo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.